Variable | Crude rate metachronous PM after median FU of 16.5 months | Multivariable Cox regression analysis* | ||
---|---|---|---|---|
n (%) | HR | 95% CI | p-value | |
Weight category | ||||
1. (BMI < 18.5); underweight | 1 (1.1) | 0.162 | 0.023–1.159 | 0.125 |
2. (BMI 18.5–25); normal weight | 107 (5.4) | Ref | Ref | Ref |
3. (BMI 25–30); overweight | 117 (5.2) | 1.065 | 0.819–1.386 | 0.638 |
4. (BMI ≥ 30); obesity | 53 (4.8) | 1.017 | 0.730–1.159 | 0.919 |
Tumor differentiation | ||||
Good/moderate | 206 (4.7) | Ref | Ref | Ref |
Poor/undifferentiated | 38 (8.7) | 1.232 | 0.862–1.761 | 0.252 |
Tumor stage | ||||
T0–2 | 20 (1.0) | Ref | Ref | Ref |
T3 | 152 (5.5) | 4.003 | 2.456–6.525 | < 0.001 |
T4 | 106 (17.0) | 11.447 | 6.844–19.14 | < 0.001 |
Nodal stage | ||||
N0 | 51 (2.0) | Ref | Ref | Ref |
N1 | 118 (6.5) | 2.038 | 1.456–2.852 | < 0.001 |
N2 | 107 (11.0) | 2.836 | 1.898–4.045 | < 0.001 |
Tumor histology | ||||
Adenocarcinoma | 233 (4.7) | Ref | Ref | Ref |
Mucinous adenocarcinoma | 34 (8.2) | 1.979 | 1.313–2.983 | 0.001 |
Signet ring cell carcinoma | 11 (24.4) | 4.455 | 2.247–8.831 | < 0.001 |
Synchronous systemic metastasis | ||||
Yes | 68 (15.9) | 3.045 | 2.279–4.068 | < 0.001 |
No | 210 (4.2) | Ref | Ref | Ref |